Servier
Key Highlights
- Servier's unique governance model, preserving independence and enabling long-term strategic vision.
- Significant investment in oncology R&D, aiming to become a leader in rare cancers.
- Focus on precision medicine in neurology for targeted therapeutic responses.
- Commitment to offering a range of generic drugs for widespread access to quality care.
- Global presence with medicines available in nearly 140 countries.
About Servier
Servier is a global pharmaceutical group headquartered in Suresnes, France, founded in 1954. It is governed by a non-profit Foundation and is committed to therapeutic progress to serve patient needs. Servier specializes in cardiometabolism, venous diseases, oncology, and neurology, with a focus on rare cancers and precision medicine. The company offers a range of generic drugs and is available in nearly 140 countries. In 2023/2024, Servier achieved sales revenue of €5.9 billion and EBITDA of €1.3 billion.
Servier's unique governance model preserves its independence and allows it to adopt a long-term vision. The company devotes close to 70% of its R&D budget to oncology, aiming to become a focused and innovative player in rare cancers. Neurology is also a future growth driver for Servier, leveraging precision medicine for targeted therapeutic responses.
Servier employs over 22,000 people worldwide and is dedicated to considering patient needs at every stage of the medicine life cycle. The company's commitment to quality care and lower-cost access to treatments makes it a significant player in the pharmaceutical industry.
Company Facts
| Ownership Private Company |
| Parent Company Servier Group |
Subsidiaries & Divisions
Office Locations
- United States
- Denmark
Why Contact Servier?
B2B professionals would contact Servier for potential partnerships in oncology and neurology, vendor opportunities in generic drug development, and to explore customer prospects in high-growth therapeutic areas. Servier's commitment to innovation and patient-centric care makes it a valuable partner in the pharmaceutical industry.
Who Should Contact Servier for Business?
Sales teams selling oncology and neurology treatments, recruiters seeking roles in pharmaceutical R&D, and partners offering precision medicine solutions should reach out to Servier.
Categories
- Pharmaceutical
- Oncology
- Neurology
- Precision Medicine
- Rare Cancers
- Generic Drugs
- Cardiometabolism
- Venous Diseases
- Therapeutic Progress
- Patient-Centric Care
More Pharmaceutical Companies
Frequently Asked Questions
- What does Servier do?
- Servier is an international pharmaceutical company focused on oncology, neurology, and rare diseases. It operates as a commercial-stage entity that develops scientific resources and tools for healthcare professionals.
- How many employees does Servier have?
- Servier has approximately 13.8K employees.
- Where is Servier headquartered?
- Servier is headquartered in France.
- What industry is Servier in?
- Servier operates in Pharmaceutical, Oncology, Neurology.
- When was Servier founded?
- Servier was founded in 1954.
- What is the email format at Servier?
- Servier uses the email format first.last@servier.com.
- Is Servier still active?
- Yes, Servier was verified as an active company on February 2, 2026. Data Surfer regularly validates company information to ensure accuracy.
- How do I sell to Servier?
- Research Servier's priorities and goals, identify the right decision makers and champions, monitor for buying signals, and reach out at the right time with verified contact details. Learn how Data Surfer helps.
Ready to Sell to Servier?
Get qualified leads in 10 minutes. Research prospects, find decision makers, and monitor for the perfect moment to reach out.
Last verified: February 2, 2026
Backed by startup programs from
Connect with Servier